Source: Medical Device News Magazine

Aculys: Aculys Pharma Delivers Positive Phase 3 Clinical Study Interim Analysis result of a Diazepam Nasal Spray | An Antiepileptic Drug for RX of Epileptic Seizures

Diazepam nasal spray is Japan's first nasally administered antiepileptic that has demonstrated efficacy and safety in Phase 3 clinical trials in Japan for the treatment of status epilepticus or epileptic seizures that may lead to status epilepticus.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Hidemasa Tanigaki's photo - CEO of Aculys

CEO

Hidemasa Tanigaki

CEO Approval Rating

90/100

Read more